Reduced-nicotine cigarettes for smoking cessation and reduction
Jonathan Livingstone-Banks1, Claire Ma2, Elias Klemperer3
1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
This review protocol examines the benefits and harms of reduced-nicotine cigarettes for smokers. It also assesses adjunct smoking cessation or reduction interventions when used with these cigarettes.
Area of Science:
- Public Health
- Tobacco Control
- Intervention Studies
Background:
- Cigarette smoking remains a significant public health concern globally.
- Nicotine addiction drives continued smoking behavior.
- Reduced-nicotine cigarettes are proposed as a harm reduction strategy.
Purpose of the Study:
- To assess the benefits and harms of reduced-nicotine cigarettes versus standard cigarettes for smokers.
- To evaluate smoking cessation or reduction interventions as adjuncts to reduced-nicotine cigarettes.
Main Methods:
- This is a protocol for a Cochrane Review.
- Systematic review methodology will be employed.
- Focus on intervention effectiveness and safety.
Main Results:
- Results are pending completion of the systematic review.
- Data on smoking cessation, reduction, and adverse events will be analyzed.
- Comparative effectiveness of interventions will be determined.
Conclusions:
- Findings will inform policy and clinical practice regarding reduced-nicotine cigarettes.
- Evidence will guide the use of adjunct interventions for smoking cessation.
- Potential impact on public health outcomes will be discussed.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence
Phase I Reactions: Reductive Reactions
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
